Vasoactive intestinal peptide downregulates proinflammatory TLRs while upregulating anti-inflammatory TLRs in the infected cornea

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 269-278

  Jiang, Xiaoyu ^a   McClellan, Sharon A ^a   Barrett, Ronald P ^a   Zhang, Yunfan ^a   Hazlett, Linda D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ADENYLATE CYCLASE 7; CYCLIC AMP; I KAPPA B KINASE BETA; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SILENCING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KERATITIS; LANGERHANS CELL; MACROPHAGE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; DOWN-REGULATION; FEMALE; INFLAMMATION MEDIATORS; KERATITIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TOLL-LIKE RECEPTORS; UP-REGULATION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84862857096     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200365     Document Type: Article

References (47)

1. Hazlett, L. D. 2004. Corneal response to Pseudomonas aeruginosa infection. Prog. Retin. Eye Res. 23: 1-30. (Pubitemid 38177170)
2. Hazlett, L. D., S. McClellan, B. Kwon, and R. Barrett. 2000. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive. Invest. Ophthalmol. Vis. Sci. 41: 805-810. (Pubitemid 30158892)
3. Szliter, E. A., S. Lighvani, R. P. Barrett, and L. D. Hazlett. 2007. Vasoactive intestinal peptide balances pro- and anti-inflammatory cytokines in the Pseudomonas aeruginosa-infected cornea and protects against corneal perforation. J. Immunol. 178: 1105-1114. (Pubitemid 46098857)
4. Jiang, X., S. A. McClellan, R. P. Barrett, E. A. Berger, Y. Zhang, and L. D. Hazlett. 2011. VIP and growth factors in the infected cornea. Invest. Ophthalmol. Vis. Sci. 52: 6154-6161.
5. Yu, F. S., and L. D. Hazlett. 2006. Toll-like receptors and the eye. Invest. Ophthalmol. Vis. Sci. 47: 1255-1263.
6. Huang, X., R. P. Barrett, S. A. McClellan, and L. D. Hazlett. 2005. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 46: 4209-4216. (Pubitemid 44264624)
7. Huang, X., W. Du, R. P. Barrett, and L. D. Hazlett. 2007. ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 48: 4626-4633. (Pubitemid 351260980)
8. Huang, X., W. Du, S. A. McClellan, R. P. Barrett, and L. D. Hazlett. 2006. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 47: 4910-4916. (Pubitemid 46586392)
9. Huang, X., L. D. Hazlett, W. Du, and R. P. Barrett. 2006. SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling. J. Immunol. 177: 548-556. (Pubitemid 43939168)
10. Sun, Y., M. Karmakar, S. Roy, R. T. Ramadan, S. R. Williams, S. Howell, C. L. Shive, Y. Han, C. M. Stopford, A. Rietsch, and E. Pearlman. 2010. TLR4 and TLR5 on corneal macrophages regulate Pseudomonas aeruginosa keratitis by signaling through MyD88-dependent and -independent pathways. J. Immunol. 185: 4272-4283.
11. Chorny, A., E. Gonzalez-Rey, N. Varela, G. Robledo, and M. Delgado. 2006. Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions. Regul. Pept. 137: 67-74. (Pubitemid 44810860)
12. Gomariz, R. P., A. Arranz, Y. Juarranz, I. Gutierrez-Cañas, M. Garcia-Gomez, J. Leceta, and C. Martínez. 2007. Regulation of TLR expression, a new perspective for the role of VIP in immunity. Peptides 28: 1825-1832. (Pubitemid 47361437)
13. Rudner, X. L., K. A. Kernacki, R. P. Barrett, and L. D. Hazlett. 2000. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage-inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation. J. Immunol. 164: 6576-6582. (Pubitemid 30408844)
14. Delgado, M., C. Martinez, D. Pozo, J. R. Calvo, J. Leceta, D. Ganea, and R. P. Gomariz. 1999. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6. J. Immunol. 162: 1200-1205. (Pubitemid 29035454)
15. Wu, M., S. A. McClellan, R. P. Barrett, and L. D. Hazlett. 2009. Beta-defensin-2 promotes resistance against infection with P. aeruginosa. J. Immunol. 182: 1609-1616.
16. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time quantitative PCR. Genome Res. 6: 986-994. (Pubitemid 26388091)
17. Xu, S., K. Ariizumi, G. Caceres-Dittmar, D. Edelbaum, K. Hashimoto, P. R. Bergstresser, and A. Takashima. 1995. Successive generation of antigen-presenting, dendritic cell lines from murine epidermis. J. Immunol. 154: 2697-2705.
18. Hazlett, L. D., S. A. McClellan, X. L. Rudner, and R. P. Barrett. 2002. The role of Langerhans cells in Pseudomonas aeruginosa infection. Invest. Ophthalmol. Vis. Sci. 43: 189-197. (Pubitemid 34032459)
19. Häcker, H., P. H. Tseng, and M. Karin. 2011. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat. Rev. Immunol. 11: 457-468.
20. Deng, J. C., G. Cheng, M. W. Newstead, X. Zeng, K. Kobayashi, R. A. Flavell, and T. J. Standiford. 2006. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J. Clin. Invest. 116: 2532-2542. (Pubitemid 44330152)
21. Duan, B., R. Davis, E. L. Sadat, J. Collins, P. C. Sternweis, D. Yuan, and L. I. Jiang. 2010. Distinct roles of adenylyl cyclase VII in regulating the immune responses in mice. J. Immunol. 185: 335-344.
22. Song, J., M. J. Duncan, G. Li, C. Chan, R. Grady, A. Stapleton, and S. N. Abraham. 2007. A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog. 3: e60.
23. Gomariz, R. P., I. Gutiérrez-Cañas, A. Arranz, M. Carrión, Y. Juarranz, J. Leceta, and C. Martínez. 2010. Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics. Curr. Pharm. Des. 16: 1063-1080.
24. Smalley, S. G., P. A. Barrow, and N. Foster. 2009. Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease. Clin. Exp. Immunol. 157: 225-234.
25. Chtarbanova, S., and J. L. Imler. 2011. Microbial sensing by Toll receptors: a historical perspective. Arterioscler. Thromb. Vasc. Biol. 31: 1734-1738.
26. Medzhitov, R., and C. Janeway, Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbiol. 8: 452-456.
27. Yuan, X., and K. R. Wilhelmus. 2010. Toll-like receptors involved in the pathogenesis of experimental Candida albicans keratitis. Invest. Ophthalmol. Vis. Sci. 51: 2094-2100.
28. Johnson, A. C., X. Li, and E. Pearlman. 2008. MyD88 functions as a negative regulator of TLR3/TRIF-induced corneal inflammation by inhibiting activation of c-Jun N-terminal kinase. J. Biol. Chem. 283: 3988-3996.
29. Foster, N., S. R. Lea, P. M. Preshaw, and J. J. Taylor. 2007. Pivotal advance: vasoactive intestinal peptide inhibits up-regulation of human monocyte TLR2 and TLR4 by LPS and differentiation of monocytes to macrophages. J. Leukoc. Biol. 81: 893-903. (Pubitemid 46495637)
30. Lee, H., K. Park, J. S. Kim, and S. J. Lee. 2009. Vasoactive intestinal peptide inhibits toll-like receptor 3-induced nitric oxide production in Schwann cells and subsequent sensory neuronal cell death in vitro. J. Neurosci. Res. 87: 171-178.
31. Arranz, A., I. Gutiérrez-Cañas, M. Carrión, Y. Juarranz, J. L. Pablos, C. Martínez, and R. P. Gomariz. 2008. VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts. Mol. Immunol. 45: 3065-3073.
32. Arranz, A., A. Androulidaki, V. Zacharioudaki, C. Martinez, A. N. Margioris, R. P. Gomariz, and C. Tsatsanis. 2008. Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide. Mol. Immunol. 45: 2970-2980.
33. Michelsen, K. S., T. M. Doherty, P. K. Shah, and M. Arditi. 2004. TLR signaling: an emerging bridge from innate immunity to atherogenesis. J. Immunol. 173: 5901-5907. (Pubitemid 39487741)
34. Israël, A. 2010. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb. Perspect. Biol. 2: a000158.
35. Delgado, M., and D. Ganea. 2001. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1. J. Biol. Chem. 276: 369-380. (Pubitemid 32050329)
36. Delgado, M., N. Varela, and E. Gonzalez-Rey. 2008. Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels. Glia 56: 1091-1103.
37. Anest, V., J. L. Hanson, P. C. Cogswell, K. A. Steinbrecher, B. D. Strahl, and A. S. Baldwin. 2003. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423: 659-663. (Pubitemid 36713228)
38. Wald, D., J. Qin, Z. Zhao, Y. Qian, M. Naramura, L. Tian, J. Towne, J. E. Sims, G. R. Stark, and X. Li. 2003. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4: 920-927. (Pubitemid 37098664)
39. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458. (Pubitemid 40835033)
40. Chen, X., Y. Zhao, X. Wu, and G. Qian. 2011. Enhanced expression of single immunoglobulin IL-1 receptor-related molecule ameliorates LPS-induced acute lung injury in mice. Shock 35: 198-204.
41. Drexler, S. K., P. Kong, J. Inglis, R. O. Williams, C. Garlanda, A. Mantovani, A. S. Yazdi, F. Brennan, M. Feldmann, and B. M. Foxwell. 2010. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis. Arthritis Rheum. 62: 2249-2261.
42. Delgado, M., D. Pozo, C. Martinez, J. Leceta, J. R. Calvo, D. Ganea, and R. P. Gomariz. 1999. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies. J. Immunol. 162: 2358-2367. (Pubitemid 29288863)
43. Delgado, M., E. J. Munoz-Elias, R. P. Gomariz, and D. Ganea. 1999. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation. J. Immunol. 162: 4685-4696. (Pubitemid 29314869)
44. McClellan, S. A., X. Huang, R. P. Barrett, N. van Rooijen, and L. D. Hazlett. 2003. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice. J. Immunol. 170: 5219-5227. (Pubitemid 36554755)
45. Kodali, S., W. Ding, J. Huang, K. Seiffert, J. A. Wagner, and R. D. Granstein. 2004. Vasoactive intestinal peptide modulates Langerhans cell immune function. J. Immunol. 173: 6082-6088. (Pubitemid 39487764)
46. Krutzik, S. R., M. T. Ochoa, P. A. Sieling, S. Uematsu, Y. W. Ng, A. Legaspi, P. T. Liu, S. T. Cole, P. J. Godowski, Y. Maeda, et al. 2003. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 9: 525-532. (Pubitemid 36597097)
47. Weng, Y., J. Sun, Q. Wu, and J. Pan. 2007. Regulatory effects of vasoactive intestinal peptide on the migration of mature dendritic cells. J. Neuroimmunol. 182: 48-54. (Pubitemid 46026706)